Detry O, Detroz B, D'Silva M, et al. Misdiagnosed malignancy in transplanted organs. Transpl Int. 1993;6:50-54.
Hynes CF, Ramakrishnan K, Alfares FA, et al. Risk of tumor transmission after thoracic allograft transplantation from adult donors with central nervous system neoplasm-a UNOS database study. Clin Transplant. 2017;31:e12919. https://doi.org/10.1111/ctr.12919
Detry O, Honore P, Hans MF, Delbouille MH, Jacquet N, Meurisse M. Organ donors with primary central nervous system tumor. Transplantation. 2000;70:244-248; discussion 251-252.
Detry O, Honore P, Meurisse M, Bonnet P, Jacquet N. Malignancy transplantation with graft: do patients with primary central nervous system tumors have to be excluded from the donor pool? Transpl Int. 1997;10:83-84.
Watson CJ, Roberts R, Wright KA, et al. How safe is it to transplant organs from deceased donors with primary intracranial malignancy? An analysis of UK Registry data. Am J Transplant. 2010;10:1437-1444.
Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW. Deceased donors with a past history of malignancy: an Organ Procurement and Transplantation Network/United Network for Organ Sharing update. Transplantation. 2007;84:272-274.
Armanios MY, Grossman SA, Yang SC, et al. Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature. Neuro Oncol. 2004;6:259-263.
